Aller au contenu principal
Accès ouvert déclaré2017article

Clinical and biochemical study of D-serine metabolism among schizophrenia patients

0Citations signalées
0Institutions associées
0Pays d’affiliation

Résumé fourni par la source

Hamdy N El-Tallawy,1 Tahia H Saleem,2 Abdallah MAA El-Ebidi,3 Mohammed H Hassan,4 Romany H Gabra,1 Wafaa MA Farghaly,1 Nagwa Abo El-Maali,5 Hoda S Sherkawy3 1Department of Neuropsychiatry, 2Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Assiut University, Assiut, 3Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Aswan University, Aswan, 4Department of Medical Biochemistry and Molecular Biology, Qena Faculty of Medicine, South Valley University, Qena, 5Department of Chemistry, Faculty of Science, Assiut University, Assiut, Egypt Background: Schizophrenia is a typical N-methyl-d-aspartate receptor (NMDA-R) hypofunction disorder. Decreased d-serine (d-Ser) levels in the periphery occur in schizophrenia and may reflect decreased availability of d-Ser to activate NMDA-R in the brain.Objective: The objective of this study was to investigate the role of d-Ser metabolism in the pathogenesis of schizophrenia via biochemical assays and correlates, the serum level of d-Ser, d-serine racemase (SR) (responsible for its formation from l-serine [l-Ser]) and d-amino acid oxidase (DAAO) (responsible for its catabolism), among different clinical types of schizophrenia patients.Patients and methods: This cross-sectional case–control study was carried out on 100 patients and 50 controls. They were recruited from the outpatients’ psychiatric unit of the Neuropsychiatric Department of Assiut University Hospital, Upper Egypt. The type of schizophrenia was determined according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), while the severity of schizophrenia was determined according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Serum d-Ser levels were estimated using high-performance liquid chromatography (HPLC), while serum SR and DAAO were measured using commercially available enzyme-linked immunosorbent assay kits.Results: There were significantly lower mean serum levels of d-Ser and SR and significantly higher mean serum levels of DAAO (P-value <0.01 for each) among schizophrenia patients when compared with the control group. Paranoid schizophrenia had the highest frequency, with a significantly lower serum levels of d-Ser and SR in the residual type and significantly higher serum levels of DAAO in undifferentiated and catatonic types. Combined receiver-operating characteristic curve for serum d-Ser, SR and DAAO indicated that the best serum level cutoff points at which schizophrenia manifestations started to appear were ≤61.4 mg/L for d-Ser, ≤15.5 pg/mL for SR and >35.6 pg/mL for DAAO.Conclusion: The present study confirms that disturbed d-Ser metabolism could be implicated in the pathogenesis of schizophrenia. Keywords: d-serine, serine racemase, d-amino acid oxidase, schizophrenia, HPLC

Sujets associés

Amino Acid Enzymes and MetabolismDiet and metabolism studiesCancer, Hypoxia, and Metabolism

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.